ArticlePharmaceutics2022

Identification of Novel Loci Involved in Adalimumab Response in Crohn's Disease Patients Using Integration of Genome Profiling and Isoform-Level Immune-Cell Deconvoluted Transcriptome Profiling of Colon Tissue.

Mario Gorenjak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.